Biotechnology ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director July 5, 2022
Biotechnology ROSEN, A LEADING LAW FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important July 12 Deadline in Securities Class Action – AXSM July 2, 2022
Biotechnology The Gross Law Firm Announces Class Actions on Behalf of Shareholders of RSKD, AXSM and ET July 1, 2022
Biotechnology Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Axsome Therapeutics, Inc. (AXSM) July 1, 2022
Search
Health
